// App-Quantinova.ai

5032 : Glycoprotein NMB (gpNMB) overexpression is prevalent in human cancers: pancreatic cancer, non-small cell lung cancer, head and neck cancer, and osteosarcoma

Researchers

Presenter

  • Abdel Halim

Principal Investigators

  • Rebecca G. Bagley

  • Tibor Keler

Medical Centers

  • Celldex Therapeutics, Hampton, NJ

  • Celldex Therapeutics, Inc., Needham, MA

Locations

  • United States

Companies

  • Celldex Therapeutics

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

  • Non Small Cell Lung cancer

  • Squamous cell carcinoma

  • Small cell lung cancer

  • Squamous cell carcinoma of the head and neck

  • Pancreatic cancer

  • Osteosarcoma

  • Solid malignancies

Biomarkers

  • Glycoprotein Nmb

  • Serpin B3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • NCT01997333

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved